Effect of Peiyuan Tongnao Capsule on Recovery of Neurological Impairment of Ischemic Stroke in Recovery Period and Its Mechanism of Action
10.13422/j.cnki.syfjx.20191731
- VernacularTitle: 培元通脑胶囊治疗缺血性中风恢复期神经功能缺损的康复效果及作用机制
- Author:
Fei LOU
1
;
Ying ZHOU
1
;
Ling ZHAO
1
;
Cui-lei JIANG
1
;
Meng-hai WU
1
Author Information
1. Ji'nan People's Hospital, Ji'nan 271100, China
- Publication Type:Research Article
- Keywords:
ischemic stroke;
recovery period;
liver and kidney insufficiency;
wind-phlegm and blood stasis syndrome;
Peiyuan Tongnao capsules;
inflammatory factors;
hemorheology;
neuroprotection
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2019;25(17):82-87
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To discuss the effect of Peiyuan Tongnao capsules on neurological impairment of patients with ischemic stroke at convalescence, and discuss the mechanism of action in microcirculation improvement, anti-inflammation and neuroprotection. Method: One hundred and thirty one patients were randomly divided into control group (66 cases) and observation group (65 cases) by random number table. Patients in control group were given aspirin enteric-coated tablets, 0.1 g/day, simvastatin tablets, 10 mg/days, and treated by percutaneous nerve electrical stimulator for 30 times, 30 min/time, 1 time/day, 5 times/week. In addition of the therapy in control group, patients in observation group were also given Peiyuan Tongnao capsules, 3 grains/time, 3 times/days. A course of treatment was 12 weeks. Before treatment, and at the 4th, 8th and 12th weeks, neurological deficits in the national institutes of health (NIHSS), activity of daily life scale (ADL), berg balance scale (BBA), fugl-meyer scale (FMA) and traditional Chinese medicine (TCM) syndromes were scored. And levels of brain-derived neurotrophic factor (BDNF), neuron-specific enolase (NSE), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), homocysteine (Hcy) and serum cystatin C (Cys-C) and hemorheological indicators whole blood viscosity, high shear rate, low shear rate, reduced viscosity, plasma viscosity, platelet aggregation rate, fibrinogen (FIB) and blood sedimentation rate (ESR)were detected. Result: At the 8th and 12th week after treatment, score of NIHSS in observation group was lower than that in control group (P<0.01), and NIHSS in observation group declined more than that in control group (P<0.01). Scores of ADL, BBA and FMA and levels of BDNF were higher than those in control group (P<0.01), while scores of TCM syndromes and levels of NSE, IL-6, TNF-α, Hcy, Cys-C and hemorheological indices were all lower than those in control group (P<0.01). And by rank sum test, the clinical effect in observation group was superior to that in control group (P<0.05). Conclusion: Peiyuan Tongnao capsules can promote the recovery of neurological impairment at recovery period of ischemic stroke, regulate inflammatory factors, improve blood rheology, protect neural function, and improve the effect of routine western medicine rehabilitation therapy.
